Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARVINAS, INC. | Chief Medical Officer | Common Stock | 67.5K | $3.18M | $47.05 | Feb 23, 2024 | Direct |
ARVINAS, INC. | Chief Medical Officer | Stock Option (right to buy) | 58.1K | $930K | $16.00 | Feb 23, 2024 | Direct |
ARVINAS, INC. | Chief Medical Officer | Restricted Stock Units | 0 | Aug 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARVN | ARVINAS, INC. | Feb 23, 2024 | 3 | -$79.9K | 4 | Feb 27, 2024 | Chief Medical Officer |
ARVN | ARVINAS, INC. | Aug 11, 2023 | 3 | -$32.3K | 4 | Aug 14, 2023 | Chief Medical Officer |
ARVN | ARVINAS, INC. | Feb 22, 2023 | 2 | $0 | 4 | Feb 24, 2023 | Chief Medical Officer |
ARVN | ARVINAS, INC. | Aug 12, 2022 | 3 | -$69K | 4/A | Aug 16, 2022 | Chief Medical Officer |
ARVN | ARVINAS, INC. | Feb 23, 2022 | 1 | $0 | 4 | Mar 4, 2022 | Chief Medical Officer |
ARVN | ARVINAS, INC. | Dec 30, 2021 | 6 | -$782K | 4 | Jan 4, 2022 | Chief Medical Officer |
ARVN | ARVINAS, INC. | Aug 12, 2021 | 3 | -$123K | 4 | Aug 16, 2021 | Chief Medical Officer |
ARVN | ARVINAS, INC. | Jun 30, 2021 | 3 | -$586K | 4 | Jul 2, 2021 | Chief Medical Officer |